Abstract
Background:
Laggera aurita belongs to the Asteraceae family; it is an annual herb found growing as weeds in Sub-Saharan Africa, including Nigeria. In Nigeria, Laggera aurita is used as a remedy for paediatric malaria and in the management of epilepsy. Previous studies on extracts of this plant suggested its anticonvulsant activity via GABA-mediated neurotransmission. Therefore, this study aimed at evaluating anxiolytic-like effect of the plant extract.Methods:
Anxiolytic potential of the methanol leaf extract of Laggera aurita was evaluated using staircase, elevated plus maze, hole board, open field, beam walking assay, and diazepam-induced sleep tests.Results:
The extract significantly (P < 0.05) decreased the number of rearing in the staircase test at 600 and 300 mg/kg. In the elevated plus maze test, there was a significant (P < 0.05 at 600 and 300 mg/kg) increase in the total number of open arm entries and total time spent in the open arms (600 mg/kg). In the hole board test, the extract significantly (P ≤ 0.05 at 600mg/kg) decreased the number of head dips. Using the open field test, the axiolytic activity of the extract was further reflected by the significant (P < 0.05) decrease in the number of rearing (150, 300, and 600 mg/kg). The effect of the extract on beam walking assay showed a significant (P < 0.05) increase (600 mg/kg) in number of foot slips and time spent on beam. The extract (600 mg/kg) significantly (P < 0.05) increased the duration of sleep induced by diazepam.Conclusions:
The results of this study revealed that the leaf extract of Laggera aurita possesses anxiolytic-like properties.Keywords
1. Background
Anxiety disorders are the most prevalent class of mental disorders and have posed a substantial public health burden (1). These disorders are regarded as a global health burden, affecting a large population (2, 3). Nigerians are the most affected in Africa with over 5 million patients with anxiety disorder (4). The common medicines for anxiety disorders are benzodiazepines and antidepressants (5, 6). However, side effects, such as psychomotor impairment, decreased alertness, sexual dysfunction, reliance liability, and potentiating activity of other sedatives, have limited their use (7).
Laggera aurita Linn (Asteraceae) is native to Sub-Saharan Africa and is a herbaceous plant found growing as a weed in Nigeria (8). Essential oils from the plant of L. aurita are used for the treatment of different diseases, such as cancer, atherosclerosis, and thrombosis (9). Anticonvulsant activity (10), anti-inflammatory and analgesic activity (11), antiviral, antibacterial and hepatoprotective properties (12), and antinociceptive properties (13), have been reported by previous studies. The traditional use of the plant in epilepsy (10) and paediatric malaria have also been reported (14). This study aimed at establishing the anxiolytic property of methanol leaf extract of Laggera aurita (LAME).
2. Methods
2.1. Drugs and Equipment
Diazepam (Roche Product Ltd.), methanol (Sigma-Aldrich, St.Louis U.S.A.), stair case apparatus, elevated plus maze apparatus, hole board apparatus, open field apparatus and beam walk apparatus were the drugs and material used in this study.
2.2. Preparation of Plant Material
The leaves of Laggera aurita Lam were collected in March 2017, from Kakiyaye village, Zaria, Nigeria. The plant was identified by Mallam Baha’uddeen of the herbarium unit, department of plant biology, Bayero University Kano. A voucher specimen number (BUKHAN 0138) was collected for future reference. The sample was washed, dried under shade, pound using mortar, and pestle into coarse powder. A portion (1250 g) of the powdered leaves was cold-macerated in methanol (2.5 Litres) for 5 days. The solvent was decanted in an evaporating dish and evaporated to dryness over a water bath, maintained at about 40°C. The dried methanol leaf extract of Laggera aurita was stored in an air-tight container. The solutions of the extract were always freshly prepared for each study by dissolution of the appropriate amount required in distilled water.
2.3. Animas
Adult Swiss albino mice of both genders (16 to 22 g) were obtained from the department of pharmacology, Bayero University, Kano, Nigeria. They were maintained under standard experimental conditions with access to animal feeds (Excel Feeds Plc, Kaduna, Nigeria) and water. All experiments performed were in accordance with the Bayero University research policy guidelines on use and care of animals.
2.4. Experimental Groupings and Treatments
Mice were randomly grouped to 5 groups of 6 mice each. Group 1 served as the control group and was treated with distilled water (10 mL/kg); groups 2, 3, and 4 were treated with the extract at 600, 300, and 150 mg/kg, respectively, while those in group 5 received diazepam at either 0.5 or 1 mg/kg, except in the diazepam-induced sleep experiment. Treatments were via the Intraperitoneal route (i.p) and observation period for recording the behavioural episodes was 30 minutes post treatment in each experiment.
2.5. Staircase Test
The method was adopted as described by Simiand et al. (15). The staircase is composed of 5 identical steps, 2.5 cm high, 10 cm wide, and 7.5 cm deep. Mice were placed individually on the floor of the box with their back to the staircase. The number of steps climbed and the number of rearing were counted over a 5-minute period.
2.6. Elevated Plus Maze Test (EPM)
This method was described by Pellow and File (16). It consists of 2 open arms (35 × 5 cm) crossed with 2 closed arms (35 × 5 × 20 cm) elevated about 25 cm in a dimly illuminated room. Mice were placed individually in the centre of the EPM, facing a closed arm. The time spent in both the open and closed arms were recorded for 5 minutes and the numbers of entries into the open and closed arms were also counted. An entry was regarded as when all 4 paws are within the arm. Increase in the open arm exploration time was regarded as anxiolysis.
2.7. Hole-Board Test for Exploratory Behaviour
This study was described by Sonavane et al. (17). It was conducted using a wooden board measuring 20 cm by 40 cm with 16 evenly spaced holes. Individual mice were placed on the board and allowed to explore, the number of times each mouse dipped its head into the holes to the level of eyes was counted during a 5-minute period. Anxiolytic compounds were considered to increase the number of head dips.
2.8. Open Field Test
Open Field Test, as described by Kulkarni and Reddy (18), was adopted. It is a floor of half square meter divided to a series of 25 squares, each alternatively coloured black and white with a 40-cm height wall. Numbers of squares travelled, time spent at the central square, and the number of rearing by the animals were counted for 5 minutes. Number of squares travelled, number of rearing, and time spent at the central square were observed and recorded.
2.9. Beam Walk Assay of Motor Coordination Deficit
This method was carried out as described by Stanley et al. (19). The beam was made of wood 8-mm in diameter, 60 cm long, and elevated 30 cm above the bench by metal supports. Adult mice were trained to walk from a start platform along a ruler (80 cm long and 3 cm wide) elevated 30 cm above the bench by a metal support to a goal box. Each mouse was placed on the beam at one end and allowed to walk to the goal box. Mice that fell were returned to the position they fell from, with a maximum time of 60 seconds allowed on the beam. The indices recorded for each mouse were time spent while crossing the beam and the number of foot slips.
2.10. Diazepam-Induced Sleep Test
The method was adopted as described by Rakotonirina et al. (20). Mice were divided to 4 groups of 6 mice each and received different treatments. Group 1 were treated with distilled water (10 mL/kg, IP) while groups 2, 3, and 4 were treated with 3 doses of the plant extracts at 600, 300, and 150 mg/kg, respectively. Thirty minutes post treatment, each group received diazepam at a dose of 20 mg/kg (IP) and the sleep potentiating effects of the plant extract was studied. The onset and duration of sleep were recorded. Loss of righting reflex was described as the onset of sleep while the time between the loss and regaining of the righting reflex was regarded as duration of sleep.
2.12. Statistical Analysis
Data analysis was conducted using one-way analysis of variance (ANOVA) followed by Dunnett’s post-hoc test (SPSS Version 20). Values obtained were expressed as mean ± standard error of the mean (SEM) and differences were considered at P ≤ 0.05.
3. Results
The extract showed a decrease in the number of steps climbed at all the doses (600, 300, and 150 mg/kg). There was also decreased number of rearing at all doses yet was significant (P < 0.05) at doses 600 and 300 mg/kg (Table 1).
Effect of Laggera Aurita Methanol Extract (LAME) on Staircase Test in Mice (N = 6)
For elevated plus maze, LAME at a dose of 600 mg/kg, significantly (P < 0.05) increased the time spent and the number of entry in the open arms. The effect at 300 mg/kg on time spent in open arms was also significantly (P < 0.05) increased compared with the control group (Table 2).
Effect of Laggera aurita Methanol Extract (LAME) on Elevated Plus Maze Test in Mice (N = 6)
| Treatment, mg/kg | Mean No. of Open Arms Entry | Mean No. of Close Arms Entry | Mean Time Spent on Open Arms, s | Mean Time Spent on Close Arms, s |
|---|---|---|---|---|
| D/water, 10 mL/kg | 3.17 ± 0.65 | 11.16 ± 1.40 | 20.17 ± 3.00 | 239.17 ± 11.97 |
| LAME (150) | 2.00 ± 0.36 | 7.00 ± 1.78 | 43.33 ± 18.62 | 195.00 ± 21.56 |
| LAME (300) | 3.00 ± 0.36 | 8.50 ± 1.09 | 71.67 ± 5.43a | 290.00 ± 20.00 |
| LAME (600) | 6.17 ± 0.47a | 5.83 ± 0.79 | 96.67 ± 12.83a | 209.33 ± 24.53 |
| DZP (0.5) | 11.33 ± 0.56a | 9.50 ± 2.68 | 91.17 ± 15.10a | 222.00 ± 17.17 |
The extract showed decrease in the number of head dipping at all doses, which was significant (P < 0.05) at 600 mg/kg; this was also observed with the diazepam-treated group compared to the control group (Table 3).
Effect of Laggera aurita Methanol Extract (LAME) on Hole Board Test in Mic (N = 6)
| Treatment, mg/kg | Mean Number of Head Dips |
|---|---|
| D/water, 10 mL/kg | 15.16 ± 1.35 |
| LAME (150) | 12.67 ± 2.20 |
| LAME (300) | 8.83 ± 2.47 |
| LAME (600) | 7.00 ± 1.95a |
| DZP (1) | 9.67 ± 1.26 |
All the doses of the extract showed a significant (P < 0.05) decrease in the number of rearing, an increase in the number of squares crossed by the diazepam-treated group and the group treated with 600 mg/kg of extract, a decrease in time spent at the central square for groups treated at the doses of 150 and 300 mg/kg, while an increase with 600 mg/kg (Table 4).
Effect of Laggera aurita Methanol Extract (LAME) on Open Field Test in Mice (N = 6)
| Treatment | Mean No. of Squares Crossed | Mean Time Spent on Central Square | Mean No. of Rearing |
|---|---|---|---|
| D/water, 10 mL/kg | 69.50 ± 7.49 | 5.50 ± 1.31 | 21.33 ± 2.56 |
| LAME (150) | 54.83 ± 15.46 | 3.17 ± 1.45 | 8.83 ± 3.07a |
| LAME (300) | 67.67 ± 16.25 | 1.83 ± 0.79 | 4.50 ± 1.73a |
| LAME (600) | 74.17 ± 20.02 | 7.00 ± 3.25 | 9.67 ± 4.06a |
| DZP (1) | 78.67 ± 29.60 | 4.33 ± 1.47 | 3.83 ± 3.44a |
The extract showed a significant (P < 0.05) increase in the number of foot slips and time spent on beam at 600 mg/kg compared to the control group (Table 5).
Effect of Laggera aurita Methanol Extract (LAME) on Beam Walking Assay in Mice (N = 6)
The extract showed increase in duration of sleep at 600 mg/kg, which was significant (P < 0.05) and a decrease in the onset of sleep at 600 and 300 mg/kg, compared to the control group (Table 6).
Effect of Laggera aurita Methanol Extract (LAME) on Diazepam-Induced Sleeping Time in Mice (N = 6)
4. Discussion
The staircase test is a differential test based on the exploratory tendency of mice when exposed to a new environment, and thus describes the level of emotivity in the mice (21). Compounds that reduce rearing activity are said to possess anxiolytic activity (22). The extract suppresses the rearing behaviour significantly and therefore suggests a central anxiolytic effect.
To further ascertain the anxiolytic effect of the extract, elevated plus maze (EPM) test was conducted. The test has been validated as an identifier of novel anxiolytic agents and found sensitive to benzodiazepines (23). In this test, it is assumed that animals felt safe in the closed arms yet exhibited fear and anxiety during exploration of the open arms (24). An anxiolytic agent increases the frequency of entry in the open arms and increases the time spent in open arms (25). The extract significantly increased the number of open arm entry and also time spent in the open arm. This could also be an indication of the anxiolytic effect of the extract, which may be due to an increase in GABAergic neurotransmission.
The behavioural episode of head dipping in hole-board assay is a sensitive measure of emotional changes; an increase in head dipping behaviour has been described as anxiolysis, where as a decrease in this parameter signifies sedation (26). The extract produced a decrease in exploratory behaviour as indicated by decrease in the number of head dips. Thus, this reflects the sedative property of the extract. Diazepam produced a decrease in the number of head dips at the dose of 1 mg/kg, an indication of the biphasic profiles of diazepam as an anxiolytic, thus, shows an enhanced explorative behaviour at low doses and an inhibition at high doses (27).
Open field test is a model for evaluating anxiety and exploration as well as locomotion. Decrease in anxiety leads to increased exploratory behaviour, decreased time spent on the central square, while an increase in anxiety results in less locomotor motion and preference for the edges of the field (28). The axiolytic activity of the extract was also indicated by significant decrease in the number of rearing. However, there was neither a significant increase in the number of squares crossed nor decrease in time spent on the central square.
The mouse beam walking assay was used to evaluate the effect of the extract on motor coordination. It is a more sensitive model in predicting clinical sedation in humans caused by novel drugs (19). The effect of LAME on beam-walking assay of motor coordination deficit showed a significant increase in the number of foot slips and time spent on beam. Therefore, the increase in the number of foot slips could be considered as the peripheral muscle relaxant activity and sedative effect of the plant extract.
In the diazepam-induced sleeping time, diazepam exerts its sedative effect by enhancing GABA inhibitory neurotransmission (29). The extract significantly increased the duration of sleep induced by diazepam, which may therefore contribute to the sleep-inducing property observed. Compounds that decrease the onset of sleep are considered to be beneficial in initiation of sleep, while agents that prolong the duration of sleep may be beneficial in sleep maintenance (20). Available literature reports describe diazepam as anxiolytic at low doses and sedative at high doses (30). It could be observed that anxiolytic activities of LAME were seen at lower doses and the sedative effect were reflected more at the higher doses. Therefore, this could explain the possible relationship between the effects of the extract and diazepam.
4.1. Conclusion
The methanol leaf extract of Laggera aurita possesses anxiolytic-like properties comparable to diazepam. This could lend additional credence to the previously reported anticonvulsant activity of the plant extract.
Acknowledgements
References
-
1.
Kabir MSH, Mohammad MH, Mominur R, Shakhawat H. Antidepressant, Anxiolytic and anti-nociceptive activities of ethanol extract of steudnera colocasiifolia K. Koch leaves in mice model. J Coastl Life Med. 2015;3(11):890-4.
-
2.
Shri R. Anxiety: causes and management. Intl J Behav Sci. 2010;5(1):243-8.
-
3.
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-96. [PubMed ID: 23245607]. https://doi.org/10.1016/S0140-6736(12)61729-2.
-
4.
World Health Organisation (WHO). Nigerians are the Most Depressed in Africa. 2017. Available from: http://www.medicalworldnigeria.com/2017/02.
-
5.
Davidson JR. First-line pharmacotherapy approaches for generalized anxiety disorder. J Clin Psychiatry. 2009;70 Suppl 2:25-31. [PubMed ID: 19371504]. https://doi.org/10.4088/JCP.s.7002.05.
-
6.
Roger W, Cate W. Clinical Pharmacy and Therapeutics. 5th ed. London, United Kingdom: Churchill Livingstone; 2011. 454 p.
-
7.
Latha K, Rammohan B, Sunanda BP, Maheswari MS, Mohan SK. Evaluation of anxiolytic activity of aqueous extract of Coriandrum sativum Linn. in mice: A preliminary experimental study. Pharmacognosy Res. 2015;7(Suppl 1):S47-51. [PubMed ID: 26109787]. https://doi.org/10.4103/0974-8490.157996.
-
8.
Burkhill HM. The Useful Plants of West Tropical Africa. 1. Kew England: Botanical Gardens; 1985. p. 452-3.
-
9.
Edris AE. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review. Phytother Res. 2007;21(4):308-23. [PubMed ID: 17199238]. https://doi.org/10.1002/ptr.2072.
-
10.
Malami S, Kyari H, Danjuma NM, Ya'u J, Hussaini IM. Anticonvulsant properties of methanol leaf extract of Laggera Aurita Linn. F. (Asteraceae) in laboratory animals. J Ethnopharmacol. 2016;191:301-6. [PubMed ID: 27321277]. https://doi.org/10.1016/j.jep.2016.06.035.
-
11.
Shehu A, Olurishe TO, Zezi AU, Ahmed A. Acute toxicological, analgesic and anti-inflammatory effects of Laggera aurita Linn (compositae) in mice and rats. Afr J Pharmacol Ther. 2016;5(2):65-73.
-
12.
Egharevba OH, Oladosu P, Okhale ES, Ibrahim I, Folashade KO, Okwute KS, et al. Preliminary anti-tuberculosis screening of two Nigerian Laggera species (Laggera pterodonta and Laggera aurita. J Med Plant Res. 2010;4(12):1235-7.
-
13.
Olurishe TO, Mati FG. Anti hyperalgesic potentials of Laggera aurita in Swiss Albino mice. Pak J Pharm Sci. 2014;27(1):169-72. [PubMed ID: 24374444].
-
14.
Odugbemi T. Medicinal Plants From Nigeria. 1. Lagos Nigeria: University of Lagos press; 2008. 581 p.
-
15.
Simiand J, Keane PE, Barnouin MC, Keane M, Soubrie P, Le Fur G. Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist. Fundam Clin Pharmacol. 1993;7(8):413-27. [PubMed ID: 7904976].
-
16.
Pellow S, File SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav. 1986;24(3):525-9. [PubMed ID: 2871560]. https://doi.org/10.1016/0091-3057(86)90552-6.
-
17.
Sonavane GS, Sarveiya VP, Kasture VS, Kasture SB. Anxiogenic activity of Myristica fragrans seeds. Pharmacol Biochem Behav. 2002;71(1-2):239-44. [PubMed ID: 11812528]. https://doi.org/10.1016/S0091-3057(01)00660-8.
-
18.
Kulkarni SK, Reddy DS. Animal behavioral models for testing antianxiety agents. Methods Find Exp Clin Pharmacol. 1996;18(3):219-30. [PubMed ID: 8738074].
-
19.
Stanley JL, Lincoln RJ, Brown TA, McDonald LM, Dawson GR, Reynolds DS. The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines. J Psychopharmacol. 2005;19(3):221-7. [PubMed ID: 15888506]. https://doi.org/10.1177/0269881105051524.
-
20.
Rakotonirina VS, Bum EN, Rakotonirina A, Bopelet M. Sedative properties of the decoction of the rhizome of Cyperus articulatus. Fitoterapia. 2001;72(1):22-9. [PubMed ID: 11163936]. https://doi.org/10.1016/S0367-326X(00)00243-4.
-
21.
Abid M, Hrishikeshavan HJ, Asad M. Pharmacological evaluation of Pachyrrhizus erosus (L) seeds for central nervous system depressant activity. Indian J Physiol Pharmacol. 2006;50(2):143-51. [PubMed ID: 17051733].
-
22.
Ennaceur A, Chazot PL. Preclinical animal anxiety research - flaws and prejudices. Pharmacol Res Perspect. 2016;4(2). e00223. [PubMed ID: 27069634]. https://doi.org/10.1002/prp2.223.
-
23.
Khan I, Karim N, Ahmad W, Abdelhalim A, Chebib M. GABA-A Receptor Modulation and Anticonvulsant, Anxiolytic, and Antidepressant Activities of Constituents from Artemisia indica Linn. Evid Based Complement Alternat Med. 2016;2016:1215393. [PubMed ID: 27143980]. https://doi.org/10.1155/2016/1215393.
-
24.
Saiyudthong S, Marsden CA. Acute effects of bergamot oil on anxiety-related behaviour and corticosterone level in rats. Phytother Res. 2011;25(6):858-62. [PubMed ID: 21105176]. https://doi.org/10.1002/ptr.3325.
-
25.
Grundmann O, Nakajima J, Seo S, Butterweck V. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test. J Ethnopharmacol. 2007;110(3):406-11. [PubMed ID: 17101250]. https://doi.org/10.1016/j.jep.2006.09.035.
-
26.
Brown GR, Nemes C. The exploratory behaviour of rats in the hole-board apparatus: is head-dipping a valid measure of neophilia? Behav Processes. 2008;78(3):442-8. [PubMed ID: 18406075]. https://doi.org/10.1016/j.beproc.2008.02.019.
-
27.
Takeda H, Tsuji M, Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol. 1998;350(1):21-9. [PubMed ID: 9683010]. https://doi.org/10.1016/S0014-2999(98)00223-4.
-
28.
Treit D, Engin E, McEown K. Animal models of anxiety and anxiolytic drug action. Curr Top Behav Neurosci. 2010;2:121-60. [PubMed ID: 21309109]. https://doi.org/10.1007/7854_2009_17.
-
29.
van Rijnsoever C, Tauber M, Choulli MK, Keist R, Rudolph U, Mohler H, et al. Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci. 2004;24(30):6785-90. [PubMed ID: 15282283]. https://doi.org/10.1523/JNEUROSCI.1067-04.2004.
-
30.
Muhammad N, Saeed M, Khan H, Haq I. Evaluation of n-hexane extract of Viola betonicifolia for its neuropharmacological properties. J Nat Med. 2013;67(1):1-8. [PubMed ID: 22359189]. https://doi.org/10.1007/s11418-012-0636-0.